CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.
| Image |  |
|---|---|
| Description | scientific article published on 10 May 2017 |
| Author/s |
author: Lerong Li John V Heymach Julien Sage |
| Publication date | May 10, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |